A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer

Clinical trial NCT07543848 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07543848
Sponsor: Chongqing University Cancer Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Rectal Neoplasms Rectal Adenocarcinoma

Start date: 2026-05-01
Primary completion: 2028-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.